Fate Therapeutics, Inc. (FATE)

NASDAQ: FATE · Real-Time Price · USD

2.350

+0.020 (0.86%)

At close: Sep 25, 2026, 4:00 PM EDT

2.370

+0.020 (0.85%)

Pre-market: Sep 28, 2026, 7:05 AM EDT

Fate Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6.49	6.65	13.63	63.53	96.3	55.85
Revenue Growth	-23.36%	-51.24%	-78.55%	-34.03%	72.44%	77.66%
Cost of Revenue	84.42	91.9	118.53	157.19	320.45	215.52
Gross Profit	-77.93	-85.25	-104.9	-93.65	-224.15	-159.67
Selling, General & Admin	54.56	61.35	90.64	96.86	84.23	57.32
Operating Expenses	54.56	61.35	90.64	96.86	84.23	57.32
Operating Income	-132.49	-146.6	-195.54	-190.51	-308.39	-216.99
Interest & Investment Income	8.22	11.05	17.29	17.19	5.84	1.31
Other Non Operating Income (Expenses)	-0.62	0.34	6.73	7.3	20.32	3.53
EBT Excluding Unusual Items	-124.9	-135.22	-171.53	-166.03	-282.22	-212.15
Merger & Restructuring Charges	-1.1	-1.1	-	-	-	-
Asset Writedown	-	-	-14.74	-	-	-
Other Unusual Items	-	-	-	5.1	0.5	-
Pretax Income	-126	-136.32	-186.26	-160.93	-281.72	-212.15
Net Income	-126	-136.32	-186.26	-160.93	-281.72	-212.15
Net Income to Common	-126	-136.32	-186.26	-160.93	-281.72	-212.15
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	120	119	114	98	97	95
Shares Outstanding (Diluted)	120	119	114	98	97	95
Shares Change	1.19%	4.49%	15.52%	1.64%	2.19%	15.00%
EPS (Basic)	-1.05	-1.15	-1.64	-1.64	-2.91	-2.24
EPS (Diluted)	-1.05	-1.15	-1.64	-1.64	-2.91	-2.24
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-105.66	-112.04	-123.6	-138.42	-283.77	-213.57
Free Cash Flow Per Share	-0.88	-0.94	-1.09	-1.41	-2.93	-2.25
Gross Margin	-	-	-	-147.41%	-232.77%	-285.92%
Operating Margin	-2041.13%	-2205.90%	-1434.52%	-299.86%	-320.24%	-388.56%
Profit Margin	-1941.09%	-2051.08%	-1366.46%	-253.30%	-292.55%	-379.89%
Free Cash Flow Margin	-1627.76%	-1685.78%	-906.79%	-217.87%	-294.68%	-382.43%
EBITDA	-120.5	-133.7	-176.58	-172.23	-294.63	-211.14
EBITDA Margin	-	-	-	-271.09%	-	-
D&A For EBITDA	11.99	12.9	18.96	18.28	13.76	5.85
EBIT	-132.49	-146.6	-195.54	-190.51	-308.39	-216.99
EBIT Margin	-	-	-	-299.86%	-	-

SEC Filings: 10-K · 10-Q